Cancer Network’s Around the Practice Series “ASCO GI 2024: Updates in MRD Testing for the Management of Colorectal Cancer”

Cancer Network posts 15-episode series “ASCO GI 2024: Updates in MRD Testing for the Management of Colorectal Cancer” in which medical oncologists highlight clinical trials presented at ASCO GI 2024 and discuss the utility of minimal residual disease (MRD) and circulating tumor DNA (ctDNA).